Drugs / VVG203
Trials 1 · a red edge is where a trial was stopped
| Phase | Registry id | Dates | Indication | Sponsor | Status | Outcome |
|---|---|---|---|---|---|---|
| Phase 1 | NCT00000868 | ? → May 2000 | HIV infectious disease | National Institute of Allergy and Infectious Diseases (NIAID) | Completed | No outcome recorded |
Evidence & citations 3 cited values
Every value below carries the sentence it was read from. 1 source stands behind the page.
| Field | Value | Cited text |
|---|---|---|
| Known as | VVG203 | “single oral dose of Salmonella typhi CVD 908-HIV-1 LAI gp 120 (VVG203)” NCT00000868 ↗ |
| Known as | Salmonella typhi CVD 908-HIV-1 LAI gp 120 | “Salmonella typhi CVD 908-HIV-1 LAI gp 120 (VVG 203)” NCT00000868 ↗ |
| Route | Oral | “single oral dose of Salmonella typhi CVD 908-HIV-1 LAI gp 120 (VVG203)” NCT00000868 ↗ |